NBY
NovaBay Pharmaceuticals, Inc.
Healthcare •
Biotechnology •
stocks •
XASE
• usd
$0.95
$-0.21
(-18.10%)
Loading...
SMA 20: -
SMA 50: -
SMA 200: -
| General | Valuation | Profitability | Financial Health | Trading | Ownership |
|---|---|---|---|---|---|
| Market Cap | $119.86M | EPS (ttm) | $5.16 | Current Price | $0.95 |
| Enterprise Value | $122.69M | Forward EPS | $-0.82 | Previous Close | $1.16 |
| P/E Ratio | 0.18 | ROA | -86.98% | 52W High | $19.95 |
| Forward P/E | -1.16 | ROE | -516.26% | 52W Low | $0.46 |
| PEG Ratio | - | Gross Margin | 63.32% | 50 Day Avg | $4.78 |
| P/S Ratio | 11.64 | Operating Margin | -224.38% | 200 Day Avg | $1.96 |
| P/B Ratio | -2.13 | Profit Margin | 31.48% | Volume | 2.01M |
| EV/EBITDA | -24.04 | Current Ratio | 2.00 | Avg Volume | 1.68M |
| EV/Sales | 11.91 | Quick Ratio | 1.89 | Beta | 0.01 |
| Employees | 13.00 | Debt/Equity | 59.36 | Shares Outstanding | 126.17M |
| Sector | Healthcare | Total Debt | $970.00K | Float Shares | 6.16M |
| Industry | Biotechnology | Total Cash | $2.31M | Short Float | 1.05% |
| Optionable | Yes | Cash/Share | $0.02 | Short Ratio | 0.44 |
| Dividend Yield | - | Book Value/Share | $-0.45 | % Held by Insiders | 95.11% |
| Target Price | - | Revenue (TTM) | $10.30M | % Held by Institutions | 2.73% |